Joel Greenblatt's PFE Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 875,704 shares of Pfizer Inc. (PFE) worth $21.81 M, representing 0.08% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in PFE, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2016, adding 1.58 M shares. Largest reduction occurred in Q2 2019, reducing 1.06 M shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -596,382 | Reduce 40.51% | 875,704 | $24.90 |
| Q3 2025 | +568,016 | Add 62.83% | 1.47 M | $25.48 |
| Q2 2025 | +475,105 | Add 110.76% | 904,070 | $24.24 |
| Q1 2025 | +287,925 | Add 204.14% | 428,965 | $25.34 |
| Q4 2024 | +108,494 | Add 333.36% | 141,040 | $26.53 |
| Q3 2024 | +7,070 | Add 27.75% | 32,546 | $28.94 |
| Q2 2024 | -8,214 | Reduce 24.38% | 25,476 | $27.98 |
| Q1 2024 | -26,788 | Reduce 44.29% | 33,690 | $27.75 |
| Q4 2023 | -462,443 | Reduce 88.43% | 60,478 | $28.79 |
| Q3 2023 | -9,267 | Reduce 1.74% | 522,921 | $33.17 |
| Q2 2023 | +78,965 | Add 17.42% | 532,188 | $36.68 |
| Q1 2023 | +184,535 | Add 68.68% | 453,223 | $40.80 |
| Q4 2022 | -59,149 | Reduce 18.04% | 268,688 | $51.24 |
| Q3 2022 | +6,819 | Add 2.12% | 327,837 | $43.76 |
| Q2 2022 | +29,725 | Add 10.20% | 321,018 | $52.43 |
| Q1 2022 | -82,192 | Reduce 22.01% | 291,293 | $51.77 |
| Q4 2021 | -158,691 | Reduce 29.82% | 373,485 | $59.05 |
| Q3 2021 | +54,946 | Add 11.51% | 532,176 | $43.01 |
| Q2 2021 | -11,409 | Reduce 2.33% | 477,230 | $39.16 |
| Q1 2021 | -33,529 | Reduce 6.42% | 488,639 | $36.23 |
| Q4 2020 | +12,180 | Add 2.39% | 522,168 | $36.81 |
| Q3 2020 | -421,369 | Reduce 45.24% | 509,988 | $36.70 |
| Q2 2020 | -79,258 | Reduce 7.84% | 931,357 | $32.70 |
| Q1 2020 | +196,870 | Add 24.19% | 1.01 M | $32.64 |
| Q4 2019 | +805,654 | Add 9957.41% | 813,745 | $39.18 |
| Q3 2019 | -403,692 | Reduce 98.04% | 8,091 | $35.97 |
| Q2 2019 | -1.06 M | Reduce 72.11% | 411,783 | $43.32 |
| Q1 2019 | +882,130 | Add 148.40% | 1.48 M | $42.47 |
| Q4 2018 | +140,800 | Add 31.04% | 594,441 | $43.65 |
| Q3 2018 | -819,658 | Reduce 64.37% | 453,641 | $44.07 |
| Q2 2018 | -140,811 | Reduce 9.96% | 1.27 M | $36.28 |
| Q1 2018 | +1.36 M | Add 2732.64% | 1.41 M | $35.49 |
| Q4 2017 | +28,105 | Add 128.82% | 49,922 | $36.22 |
| Q3 2017 | -449,111 | Reduce 95.37% | 21,817 | $35.71 |
| Q2 2017 | -473,732 | Reduce 50.15% | 470,928 | $33.59 |
| Q1 2017 | +185,286 | Add 24.40% | 944,660 | $34.21 |
| Q4 2016 | -399,563 | Reduce 34.48% | 759,374 | $32.48 |
| Q3 2016 | -779,345 | Reduce 40.21% | 1.16 M | $33.87 |
| Q2 2016 | +361,019 | Add 22.89% | 1.94 M | $35.21 |
| Q1 2016 | +1.58 M | New Buy | 1.58 M | $29.64 |
| Q4 2015 | -1.05 M | Sold Out | 0 | $0.00 |
| Q3 2015 | +23,297 | Add 2.27% | 1.05 M | $31.41 |
| Q2 2015 | -948,224 | Reduce 48.07% | 1.02 M | $33.53 |
| Q1 2015 | +551,840 | Add 38.84% | 1.97 M | $34.79 |
| Q4 2014 | -201,144 | Reduce 12.40% | 1.42 M | $31.15 |
| Q3 2014 | -119,222 | Reduce 6.85% | 1.62 M | $29.57 |
| Q2 2014 | +726,506 | Add 71.59% | 1.74 M | $29.68 |
| Q1 2014 | +792,528 | Add 356.54% | 1.01 M | $32.12 |
| Q4 2013 | +157,230 | Add 241.71% | 222,280 | $30.63 |
| Q3 2013 | +46,958 | Add 259.55% | 65,050 | $28.73 |
| Q2 2013 | +18,092 | Add 0.00% | 18,092 | $28.02 |
Joel Greenblatt's Pfizer Investment FAQs
Joel Greenblatt first purchased Pfizer Inc. (PFE) in Q2 2013, acquiring 18,092 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Pfizer Inc. (PFE) for 51 quarters since Q2 2013.
Joel Greenblatt's largest addition to Pfizer Inc. (PFE) was in Q1 2016, adding 1,577,263 shares worth $46.75 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 875,704 shares of Pfizer Inc. (PFE), valued at approximately $21.81 M.
As of the Q4 2025 filing, Pfizer Inc. (PFE) represents approximately 0.08% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Pfizer Inc. (PFE) was 1,972,788 shares, as reported at the end of Q1 2015.